222 related articles for article (PubMed ID: 16517611)
21. Elimination of P1 arginine 393 interaction with underlying glutamic acid 255 partially activates antithrombin III for thrombin inhibition but not factor Xa inhibition.
Jairajpuri MA; Lu A; Bock SC
J Biol Chem; 2002 Jul; 277(27):24460-5. PubMed ID: 11971909
[TBL] [Abstract][Full Text] [Related]
22. The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor IXa, factor Xa, and thrombin.
Björk I; Jackson CM; Jörnvall H; Lavine KK; Nordling K; Salsgiver WJ
J Biol Chem; 1982 Mar; 257(5):2406-11. PubMed ID: 6977539
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
Pieters J; Willems G; Hemker HC; Lindhout T
J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
[TBL] [Abstract][Full Text] [Related]
24. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.
Huntington JA; Olson ST; Fan B; Gettins PG
Biochemistry; 1996 Jul; 35(26):8495-503. PubMed ID: 8679610
[TBL] [Abstract][Full Text] [Related]
25. The role of the COOH-terminal region of antithrombin III. Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor.
Nishioka J; Suzuki K
J Biol Chem; 1992 Nov; 267(31):22224-9. PubMed ID: 1331047
[TBL] [Abstract][Full Text] [Related]
26. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
27. Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.
Yang L; Manithody C; Qureshi SH; Rezaie AR
J Biol Chem; 2010 Sep; 285(37):28488-95. PubMed ID: 20628058
[TBL] [Abstract][Full Text] [Related]
28. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
[TBL] [Abstract][Full Text] [Related]
29. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
Yuan QP; Walke EN; Sheehan JP
Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
[TBL] [Abstract][Full Text] [Related]
30. Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation.
Johnson DJ; Li W; Adams TE; Huntington JA
EMBO J; 2006 May; 25(9):2029-37. PubMed ID: 16619025
[TBL] [Abstract][Full Text] [Related]
31. Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases.
Yang L; Manithody C; Rezaie AR
Blood; 2004 Sep; 104(6):1753-9. PubMed ID: 15178583
[TBL] [Abstract][Full Text] [Related]
32. Kinetic characterization of the substrate reaction between a complex of antithrombin with a synthetic reactive-bond loop tetradecapeptide and four target proteinases of the inhibitor.
Björk I; Nordling K; Larsson I; Olson ST
J Biol Chem; 1992 Sep; 267(27):19047-50. PubMed ID: 1388162
[TBL] [Abstract][Full Text] [Related]
33. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X.
Misenheimer TM; Buyue Y; Sheehan JP
Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121
[TBL] [Abstract][Full Text] [Related]
34. Molecular mapping of the heparin-binding exosite of thrombin.
Sheehan JP; Sadler JE
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5518-22. PubMed ID: 8202520
[TBL] [Abstract][Full Text] [Related]
35. Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.
Myles T; Church FC; Whinna HC; Monard D; Stone SR
J Biol Chem; 1998 Nov; 273(47):31203-8. PubMed ID: 9813026
[TBL] [Abstract][Full Text] [Related]
36. Identification of the antithrombin III heparin binding site.
Ersdal-Badju E; Lu A; Zuo Y; Picard V; Bock SC
J Biol Chem; 1997 Aug; 272(31):19393-400. PubMed ID: 9235938
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulant activities of a monoclonal antibody that binds to exosite II of thrombin.
Lian F; He L; Colwell NS; Lollar P; Tollefsen DM
Biochemistry; 2001 Jul; 40(29):8508-13. PubMed ID: 11456488
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex.
Paredes N; Wang A; Berry LR; Smith LJ; Stafford AR; Weitz JI; Chan AK
J Biol Chem; 2003 Jun; 278(26):23398-409. PubMed ID: 12695507
[TBL] [Abstract][Full Text] [Related]
39. Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors.
Fuchs HE; Trapp HG; Griffith MJ; Roberts HR; Pizzo SV
J Clin Invest; 1984 Jun; 73(6):1696-703. PubMed ID: 6202716
[TBL] [Abstract][Full Text] [Related]
40. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex.
Rezaie AR
Blood; 2001 Apr; 97(8):2308-13. PubMed ID: 11290592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
